[Immunisation of fancy chickens against Newcastle disease].

The German Regulation on Fowl plague which is in force since 1994 laid down that any chicken of all races and all hybrids must be vaccinated against Newcastle disease (ND) in a mode that an adequate immunity is achieved. Onset, duration, and resistance to challenge of immunity induced by vaccination is well documented in the scientific literature for hybrid chicken of the layer and meat types. These data prove also innocuity and efficacy of the registered vaccines.

Response of domestic geese to lentogenic and velogenic strains of Newcastle disease virus.

A total of 54 domestic white meat-type geese were included in vaccination/challenge trials to evaluate susceptibility to disease and humoral immune responses using the haemagglutination inhibition (HI) and virus neutralization (VN) tests against Newcastle disease (ND). Two groups of twenty geese, five weeks of age, were conjunctivally vaccinated with either 100 x 10(6) or 2.5 x 10(6) EID50 (egg infectious dose 50 per cent) per bird of live La Sota virus, respectively, and 14 geese remained unvaccinated.

Ferrioxamine E-supplemented pre-enrichment and enrichment media improve various isolation methods for Salmonella.

Supplementation of pre-enrichment broth and enrichment broth media with ferrioxamine E (1 microgram/ml) significantly improved the recovery of Salmonella from artificially or naturally contaminated foods. Based on the selectivity of ferrioxamine E, Salmonella enteritidis and S. typhimurium could be isolated also from various mixed cultures (one Salmonella cell in 10(3)-10(4)-fold concentration of cells of competitors) by shaking for 6 h in supplemented buffered peptone water followed by cultivation on XLD- or XLT-4 agars.

[Immunizing against salmonella infections with live and inactivated vaccines].

A live attenuated auxotrophic S. typhimurium (S. tm.

[Vaccination against infectious anemia of poultry (CAA)--results of field studies].

Infectious anemia of poultry is a disease of high economical significance. Connatal infection of chicks with the chicken anemia agent (CAA) via the embryonated egg causes anemia along with severe immunosuppression, thus rendering the chicken susceptible for secondary infections. In order to prevent infection of young chicks, it is necessary to induce immunity against CAA in parent flocks, with the aim to prevent connatal spread of the infection and provide maternal protection for baby chicks.

[The occurrence of a reovirus variant in a German broiler flock].

Broilers deriving from a parent flock, which had been effected in the 6th. month of hatching egg production, show arthritis beginning with the 12th day of life. The tarso-metatarsal joint has been affected.

Anaemia-dermatitis of broilers: field observations on its occurrence, transmission and prevention.

Anaemia-dermatitis was first observed in German broiler flocks in 1977. Its frequency has increased in the past six years. Atrophy of thymus, bursa and bone marrow occur and are affected by a severe anaemia and immunosuppression.

Differential expression of endogenous virus glycoprotein in fibroblasts and sera of some adult chickens.

A rapid and convenient assay for the expression of endogenous retrovirus glycoprotein in adult chickens has been developed based on the enzyme-linked immunosorbent assay (ELISA) principle. This method has been standardized using the conventional chick helper factor test. In the course of establishing this method with a large number of specific pathogen-free (VALO) chickens, an interesting diversity became apparent; about 20% of the birds which, according to chick helper factor tests performed with feather follicle fibroblast cultures were negative for endogenous virus glycoprotein expression, exhibited relatively high titres of reactive glycoprotein in serum.

Evaluation of a vaccine against infectious bursal disease in field trials.

It has been established in field trials that the mutant strain Cu-1M of the infectious bursal disease virus can be used for vaccination against the disease. Vaccination does not cause clinical signs or significant pathological alterations in the Bursa of Fabricius, and consequently it is not accompanied by immunosuppressive effects. In the proposed vaccination scheme maternally derived antibodies do not interfere with the establishment of immune protection in young chickens.

[Potency tests with HVT-, MHV- and JMV vaccines against Marek's disease].

Turkey herpesvirus (HVT)(FC 126) vaccine made in W. Germany, Marek's herpesvirus (MHV) (CVI 988) vaccine used in the Netherlands and experimental JMV vaccine were tested in laboratory and field trials for protection against Marek's disease. The tests were carried out with 780 SPF chicks and 3200 commercial white Leghorn chicks (with maternally derived antibodies to HVT and MHV).

Comparative tests on safety and potency of IBA vaccines.

During a comparative test on the pathogenicity and immunogenicity of a non-adapted and an embryo-adapted IDA virus, following observations were made: 1) the non-adapted virus remained pathogenic as determined by weight loss and bursal lesions. Clinical signs and mortality did not occur. A change in the virulence did not occur during back passages; 2) the immunosuppressive effect of the non-adapted virus was diminished by maternal antibodies; 3) the embryo-adapted virus produced little pathogenicity as demonstrated by minor weight depressions.